Comparison of Three DPP-4 Inhibitors on 24 Hour Blood Glucose, Incretin Hormones and Islet Function in Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Saxagliptin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms CODI24
- 22 Aug 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 25 Feb 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.